
Alemtuzumab treats relapsing forms of multiple sclerosis, but is accompanied with a 50% risk of secondary autoimmune diseases.
Alemtuzumab treats relapsing forms of multiple sclerosis, but is accompanied with a 50% risk of secondary autoimmune diseases.
Elvin Montanez, PharmD, chief operations officer at BioPlus Specialty Pharmacy, discusses optimal strategies when choosing a specialty pharmacy to partner with.
A look at last week's top stories in the world of pharmacy.
Top articles of the week on Specialty Pharmacy Times.
A next generation sequencing test to detect lung cancer mutation was also approved.
Non-small cell lung cancer vaccine harnesses peptides to increase immune response.
Top news of the day from across the health care landscape.
Subcutaneous administration of Rituxan Hycela shortens treatment length to only 5 to 7 minutes.
Forward-thinking pharmacies can capitalize on the rise of value-based care.
Patients with HIV-associated sensory neuropathy have a decrease in corneal nerve fiber density and an increase in corneal nerve tortuosity.
Could household pets be the key to treating breast carcinoma?
Restoring a tumor suppressing gene offers a promising therapeutic target for diffuse intrinsic pontine glioma.
Dabrafenib + trametinib treats patients with unresectable or metastatic melanoma who have a BRAF V600 mutation.
Onions contain one of the highest concentrations of quercetin, a flavonoid extract with anti-proliferative effects.
Top news of the day from across the health care landscape.
Tofacitinib and Guselkumab show promise in patients with PsA.
Cannabinoid treatment may alleviate some symptoms of multiple sclerosis and IBS, in addition to chemotherapy-induced nausea.
How NS5A inhibitors block hepatitis C virus replication impacts treatment outcomes.
Overutilization of care can produce disparities between high- and low-income counties.
Novel vaccine modulates T cell responses in RA.
Compounds found in turmeric, red grapes, and apple peels block cancer cells from accessing nutrients need to grow and survive.
Phase 3 study seeks to further understand the mechanisms of ocrelizumab.
Top news of the day from across the health care landscape.
Achieving linkage to care and viral suppression among patients with HIV improves overall wellbeing and prevents new infections.
Publicly-funded cancer clinical trials are high impact and low cost, experts say.
Adcetris achieves superior outcomes in the treatment of CTCL.
Incidence of stroke was 2.17% per year in patients with cirrhosis compared with 1.11% in patients without cirrhosis.
Use of plant enzymes in bacterial cell factories may lead to effective anti-cancer drugs.
Top news of the day from across the health care landscape.
Screening for drug interactions is a challenge when a patient with HIV presents with several prescriptions.